Cipla (CIPLA) — Announcement

📢 Key Event
Cipla reports ESG rating changes from SES and NSE

💡 Investor Takeaway
The ESG rating dip may signal emerging risks that could affect long-term shareholder value.

⚠️ Risks
Potential reputational impact from U.S. product recall affecting NSE rating

Cipla announced its ESG ratings from SES and NSE on August 11, 2026, showing a slight improvement in SES's adjusted rating to 69.9 (Grade B) for FY 2025-26 versus 69.3 in the prior year, while NSE's rating fell to 67 (Aspiring) from 69, partly due to a product recall by its U.S. subsidiary in January 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How will the U.S. product recall impact Cipla's U.S. revenue?" "What steps is Cipla taking to improve its NSE ESG score?" "How does Cipla's ESG performance compare to peers like Sun Pharma?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 11 August 2026

ULTRACEMCO UltraTech Cement Limited Announcement SUDEEPPHRM Sudeep Pharma Limited Financial Results SUTLEJTEX Sutlej Textiles and Industries Limited Financial Results RBZJEWEL RBZ Jewellers Limited Financial Results TATVA Tatva Chintan Pharma Chem Limited Corporate Action AETHER Aether Industries Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.